Alexandria Real Estate Equities
ARE
#2161
Rank
NZ$14.89 B
Marketcap
NZ$85.95
Share price
-2.05%
Change (1 day)
-48.98%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) Fails to deliver data

Key failure to deliver metrics for Alexandria Real Estate Equities :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alexandria Real Estate Equities (ARE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alexandria Real Estate Equities (ARE) - since 2013

Volume in USD (price x number of shares), data since 2013

Alexandria Real Estate Equities (ARE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$7.97 M-79.04%
2025NZ$38.06 M-37.06%
2024NZ$60.47 M46.83%
2023NZ$41.18 M-64.08%
2022NZ$0.11 B22.18%
2021NZ$93.85 M-16.64%
2020NZ$0.11 B38.94%
2019NZ$81.03 M-10.89%
2018NZ$90.94 M-43.57%
2017NZ$0.16 B192.01%
2016NZ$55.19 M125.93%
2015NZ$24.42 M11.4%
2014NZ$21.92 M875.57%
2013NZ$2.24 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
NZ$56.63 MNZ$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$0.11 BNZ$0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$0.21 BNZ$0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$8.23 MNZ$0.24 B๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$8.52 MNZ$18.84 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$40.01 MNZ$94.16 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$8.14 MNZ$37.9 M๐Ÿ‡บ๐Ÿ‡ธ USA